학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 323건 | 목록 1~10
Academic Journal
Garattini SK; Department of Oncology, ASUFC University Hospital, Udine, Italy.; Basile D; Department of Medical Oncology, San Giovanni di Dio Hospital, Crotone, Italy.; De Re V; Immunopathology and Cancer Biomarkers/Bio-Proteomics Facility, Centro di Riferimento Oncologico, IRCCS, Aviano, Italy.; Brisotto G; Immunopathology and Cancer Biomarkers/Bio-Proteomics Facility, Centro di Riferimento Oncologico, IRCCS, Aviano, Italy.; Miolo G; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.; Canzonieri V; Pathology Unit, IRCCS CRO National Cancer Institute, Aviano, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.; Aprile G; Department of Oncology, University and General Hospital, Udine, Italy.; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy.; Corvaja C; Division of Thoracic Oncology, European Institute of Oncology (IEO) IRCCS, Milano, Italy.; Buriolla S; Department of Oncology, ASUFC University Hospital, Udine, Italy.; Garattini E; Department of Biochemistry and Molecular Pharmacology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.; Puglisi F; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.; Departiment of Medicine, University of Udine, Udine, Italy.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Trentin L; AULSS 8 Berica Ospedale San Bortolo, Laboratory of Haematology, Vicenza, Italy.; AULSS 2 Marca Trevigiana, Histocompatibility Laboratory, Treviso, Italy.; Basile D; AULSS 8 Berica Ospedale San Bortolo, UOC Oncologia, Vicenza, Italy.; Unit of Medical Oncology, Ospedale San Giovanni di Dio, Crotone, Italy.; Lazzari E; AULSS 8 Berica Ospedale San Bortolo, UOC Anatomia Patologica, Vicenza, Italy.; Fietta E; AULSS 8 Berica Ospedale San Bortolo, Laboratory of Haematology, Vicenza, Italy.; Rossi A; AULSS 8 Berica Ospedale San Bortolo, UOC Oncologia, Vicenza, Italy.; Graziani F; AULSS 8 Berica Ospedale San Bortolo, UOC Oncologia, Vicenza, Italy.; Cappetta A; AULSS 8 Berica Ospedale San Bortolo, UOC Oncologia, Vicenza, Italy.; Simionato F; AULSS 8 Berica Ospedale San Bortolo, UOC Oncologia, Vicenza, Italy.; D'Amore E; AULSS 8 Berica Ospedale San Bortolo, UOC Anatomia Patologica, Vicenza, Italy.; Perbellini O; AULSS 8 Berica Ospedale San Bortolo, Laboratory of Haematology, Vicenza, Italy.; Aprile G; AULSS 8 Berica Ospedale San Bortolo, UOC Oncologia, Vicenza, Italy.
Publisher: Sage Publications Country of Publication: United States NLM ID: 0111356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2038-2529 (Electronic) Linking ISSN: 03008916 NLM ISO Abbreviation: Tumori Subsets: MEDLINE
Academic Journal
Antoniotti C; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Rossini D; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.; Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Salvatore L; Oncologia Medica, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.; Oncologia Medica, Università Cattolica del Sacro Cuore, Roma, Italy.; Lonardi S; Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.; Tamberi S; Oncology Unit, Ravenna Hospital, AUSL Romagna, Ravenna, Italy.; Marmorino F; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Moretto R; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy.; Prisciandaro M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Tamburini E; Department of Oncology and Palliative Care, Cardinale G Panico, Tricase City Hospital, Tricase, Italy.; Tortora G; Oncologia Medica, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.; Oncologia Medica, Università Cattolica del Sacro Cuore, Roma, Italy.; Passardi A; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy.; Bergamo F; Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.; Raimondi A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Ritorto G; SSD ColoRectal Cancer Unit, Department of Oncology, AOU Città della Salute e della Scienza di Torino, Torino, Italy.; Borelli B; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy.; Conca V; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Ugolini C; Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.; Aprile G; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy.; Antonuzzo L; Clinical Oncology Unit, Careggi University Hospital, Firenze, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy.; Gelsomino F; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.; Martinelli E; Oncologia Medica, Dipartimento di Medicina di Precisione, Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy.; Pella N; Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale University Hospital, Udine, Italy.; Masi G; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Boni L; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Galon J; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France.; Sorbonne Université, Université de Paris, Centre de Recherche des Cordeliers, Paris, France.; Equipe Labellisée Ligue Contre le Cancer, Paris, France.; Cremolini C; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Sposito M; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust/Azienda Ospedaliero-Universitaria Integrata (AOUI), Verona, Italy.; Belluomini L; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust/Azienda Ospedaliero-Universitaria Integrata (AOUI), Verona, Italy.; Nocini R; Otolaryngology-Head and Neck Surgery Department, University of Verona Hospital Trust, Verona, Italy.; Insolda J; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust/Azienda Ospedaliero-Universitaria Integrata (AOUI), Verona, Italy.; Scaglione IM; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust/Azienda Ospedaliero-Universitaria Integrata (AOUI), Verona, Italy.; Menis J; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust/Azienda Ospedaliero-Universitaria Integrata (AOUI), Verona, Italy.; Simbolo M; Department of Diagnostics and Public Health, Section of Pathology, University and Hospital Trust of Verona, Verona, Italy.; Lugini A; Medical Oncology Unit, Azienda Ospedaliera (AO) San Giovanni Addolorata Hospital, Rome, Italy.; Buzzacchino F; Medical Oncology Unit, San Giuseppe Moscati Hospital, Taranto, Italy.; Verderame F; Section of Oncology, Azienda Ospedaliera (AO) Ospedali Riuniti 'Villa Sofia- V. Cervello', Palermo, Italy.; Spinnato F; Section of Oncology, Azienda Ospedaliera (AO) Ospedali Riuniti 'Villa Sofia- V. Cervello', Palermo, Italy.; Aprile G; Department of Clinical Oncology, San Bortolo General Hospital, Azienda ULSS8 Berica, Vicenza, Italy.; Calvetti L; Department of Clinical Oncology, San Bortolo General Hospital, Azienda ULSS8 Berica, Vicenza, Italy.; Occhipinti M; Department of Experimental Medicine, Sapienza University, Rome, Italy.; Medical Oncology Department, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Dei Tumori, Milan, Italy.; Marinelli D; Department of Experimental Medicine, Sapienza University, Rome, Italy.; Division of Medical Oncology B, Policlinico Umberto I, Rome, Italy.; Veccia A; Medical Oncology Department, Santa Chiara Hospital, Trento, Italy.; Lombardo F; Lung Unit, Ospedale Pederzoli, Peschiera del Garda, Verona, Italy.; Soto Parra HJ; Medical Oncology, Azienda Ospedaliero Universitaria Policlinico 'G. Rodolico-S. Marco', Catania, Italy.; Ferraù F; Department of Medical Oncology, Unità Operativa Complessa (UOC) Oncologia, Taormina, Italy.; Savastano C; Medical Oncology Unit, San Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy.; Porta C; AdRes Health Economics and Outcome Research, Turin, Italy.; Pradelli L; AdRes Health Economics and Outcome Research, Turin, Italy.; Sicari E; Roche S.p.A., Monza, Italy.; Castellani S; Roche S.p.A., Monza, Italy.; Malapelle U; Department of Public Health, University Federico II of Naples, Naples, Italy.; Novello S; Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Italy.; Bria E; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Roma, Italy.; Medical Oncology, Università Cattolica del Sacro Cuore, Roma, Italy.; Pilotto S; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust/Azienda Ospedaliero-Universitaria Integrata (AOUI), Verona, Italy.; Milella M; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust/Azienda Ospedaliero-Universitaria Integrata (AOUI), Verona, Italy.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Caminiti C; Clinical and Epidemiological Research Unit, University Hospital, Parma, Italy.; Maglietta G; Clinical and Epidemiological Research Unit, University Hospital, Parma, Italy.; Arenare L; Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS Fondazione G.Pascale, Napoli, Italy.; Di Liello R; Division of Medical Oncology, Ospedale del Mare, Napoli, Italy.; Migliaccio G; Departmental Structure of Clinical Psycho-oncology, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli, Italy.; Barberio D; Departmental Structure of Clinical Psycho-oncology, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli, Italy.; De Laurentiis M; Experimental and Clinical Senologic Oncology Unit, Istituto Nazionale Tumori, IRCCS Fondazione G.Pascale, Napoli, Italy.; Di Rella F; Experimental and Clinical Senologic Oncology Unit, Istituto Nazionale Tumori, IRCCS Fondazione G.Pascale, Napoli, Italy.; Nuzzo F; Experimental and Clinical Senologic Oncology Unit, Istituto Nazionale Tumori, IRCCS Fondazione G.Pascale, Napoli, Italy.; Pacilio C; Experimental and Clinical Senologic Oncology Unit, Istituto Nazionale Tumori, IRCCS Fondazione G.Pascale, Napoli, Italy.; Iodice G; Experimental and Clinical Senologic Oncology Unit, Istituto Nazionale Tumori, IRCCS Fondazione G.Pascale, Napoli, Italy.; Orditura M; Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy.; Ciardiello F; Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy.; Di Bella S; Medical Oncology, ASST Rhodense, Rho (MI), Italy.; Cavanna L; Medical Oncology, Ospedale Guglielmo da Saliceto, Piacenza, Italy.; Porta C; Interdisciplinary Department of Medicine, Università degli Studi 'A. Moro', Bari, Italy; Polyclinic Consortium University Hospital, Bari, Italy.; Giovanardi F; Medical Oncology, Ospedale Civile, Guastalla (RE), Italy.; Ripamonti CI; Supportive Care Unit, istituto Nazionale Tumori, IRCCS, Milano, Italy.; Bilancia D; Medical Oncology, Ospedale S.Carlo, Potenza, Italy.; Aprile G; Medical Oncology, Azienda ULSS 8 Nerica, Ospedale S.Bortolo, Vicenza, Italy.; Ruelle T; Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties (DIMI), Università di Genova, Genova, Italy.; Diodati F; Clinical and Epidemiological Research Unit, University Hospital, Parma, Italy.; Piccirillo MC; Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS Fondazione G.Pascale, Napoli, Italy.; Iannelli E; FAVO - Federazione Italiana delle Associazioni di Volontariato in Oncologia, Roma, Italy.; Pinto C; Medical Oncology, AUSL-IRCCS, Reggio Emilia, Italy.; Perrone F; Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS Fondazione G.Pascale, Napoli, Italy. Electronic address: f.perrone@istitutotumori.na.it.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Aprile G
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어